Related Experiment Videos
Pharmacology of diuretics in the newborn
S Chemtob1, B S Kaplan, J R Sherbotie
1Developmental Pharamcology and Perinatal Research Unit, McGill University, Montreal, Quebec, Canada.
Insights
Diuretics effectively manage fluid overload in conditions like heart failure. However, their use in newborns with lung or central nervous system issues requires more research, especially for drugs beyond furosemide.
Area of Science:
- Neonatal Pharmacology
- Pediatric Nephrology
- Critical Care Medicine
Background:
- Diuretics are crucial for managing fluid overload, particularly in congestive heart failure.
- The application of diuretics in neonatal chronic lung disease and central nervous system disorders lacks established guidelines.
- Current understanding of diuretic pharmacokinetics and pharmacodynamics in neonates is limited.
Purpose of the Study:
- To highlight the need for further research into diuretic use in sick newborn infants.
- To identify gaps in knowledge regarding the pharmacodynamics, pharmacokinetics, clinical indications, and toxicity of various diuretics in neonates.
- To explore future therapeutic strategies involving diuretic combinations for refractory edema and diuretic tolerance.
Main Methods:
- Review of existing literature on diuretic use in neonatal populations.
- Analysis of pharmacokinetic and pharmacodynamic data for commonly used diuretics in infants.
- Identification of areas requiring further clinical investigation and research.
Main Results:
- Furosemide is the most studied diuretic in sick newborns, but data on others are scarce.
- Clear indications and safety profiles for many diuretics in neonatal neurological and pulmonary conditions are not well-defined.
- Diuretic tolerance is a common challenge in neonatal care.
Conclusions:
- Further comprehensive evaluation of diuretic agents beyond furosemide in neonates is essential.
- Future research should focus on optimizing diuretic therapy, including combination approaches, to manage edema and tolerance.
- Establishing evidence-based guidelines for diuretic use in specific neonatal conditions is a critical unmet need.
Abstract:
Diuretics are used in various conditions with fluid overload. Their efficacy in the management of congestive heart failure is well documented. In contrast, the indication of diuretics in chronic lung disease and central nervous system disorders of the newborn have not been clearly established. Substantial pharmacologic knowledge of diuretics in the young infant remains to be described. Most investigations on diuretics in the sick newborn infant have examined furosemide. In contrast, the pharmaco-dynamics, pharmacokinetics, clinical indications, and toxicity of other diuretics used in the newborn require considerable further evaluation. Future studies using a combination of diuretics, acting at different segments of the nephron, also may provide newer therapeutic modalities to overcome or prevent the development of frequently observed tolerance to diuretics, as well as to treat refractory edema.